Agenus Inc. (AGEN)
USD 1.7
(-7.61%)
USD 1.7
(-7.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -145.92 Million USD | 8.84% |
| 2022 | -161.84 Million USD | -427.56% |
| 2021 | 44.01 Million USD | 144.33% |
| 2020 | -114.63 Million USD | -92.04% |
| 2019 | -63.44 Million USD | 52.38% |
| 2018 | -130.48 Million USD | -9.87% |
| 2017 | -95.81 Million USD | -6.38% |
| 2016 | -104.73 Million USD | -53.91% |
| 2015 | -84.71 Million USD | -124.89% |
| 2014 | -39.64 Million USD | -19.79% |
| 2013 | -27.05 Million USD | -270.57% |
| 2012 | -4.98 Million USD | 59.96% |
| 2011 | -16.81 Million USD | 26.78% |
| 2010 | -13.59 Million USD | 8.17% |
| 2009 | -20.86 Million USD | 47.17% |
| 2008 | -37.84 Million USD | -70.13% |
| 2007 | -26.38 Million USD | 34.22% |
| 2006 | -42.93 Million USD | 38.01% |
| 2005 | -65.54 Million USD | -15.58% |
| 2004 | -63.41 Million USD | 4.87% |
| 2003 | -60.47 Million USD | -19.07% |
| 2002 | -51.9 Million USD | -1710.57% |
| 2001 | -37.47 Million USD | -464.58% |
| 2000 | -25 Million USD | 104.44% |
| 1999 | -17.85 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -29.5 Million USD | -3931.54% |
| 2024 Q2 | -26.83 Million USD | 35.69% |
| 2023 FY | - USD | 8.84% |
| 2023 Q3 | -43.04 Million USD | 15.27% |
| 2023 Q2 | -50.8 Million USD | 2.58% |
| 2023 Q4 | 842 Thousand USD | 101.96% |
| 2023 Q1 | -52.14 Million USD | 1.27% |
| 2022 Q3 | -39.4 Million USD | -15.16% |
| 2022 Q1 | -34.28 Million USD | 33.34% |
| 2022 FY | - USD | -427.56% |
| 2022 Q4 | -52.81 Million USD | -34.02% |
| 2022 Q2 | -34.22 Million USD | 0.18% |
| 2021 FY | - USD | 144.33% |
| 2021 Q2 | -51.29 Million USD | -35.59% |
| 2021 Q1 | -37.82 Million USD | -63.62% |
| 2021 Q4 | -51.43 Million USD | -127.12% |
| 2021 Q3 | 189.61 Million USD | 469.68% |
| 2020 Q4 | -23.11 Million USD | 26.35% |
| 2020 Q2 | -24.98 Million USD | 19.93% |
| 2020 Q1 | -31.2 Million USD | -145.44% |
| 2020 FY | - USD | -92.04% |
| 2020 Q3 | -31.39 Million USD | -25.65% |
| 2019 Q3 | -35.72 Million USD | 11.08% |
| 2019 Q4 | -12.71 Million USD | 64.41% |
| 2019 Q1 | 30.96 Million USD | 180.53% |
| 2019 Q2 | -40.17 Million USD | -229.74% |
| 2019 FY | - USD | 52.38% |
| 2018 Q3 | -24.73 Million USD | -4.28% |
| 2018 FY | - USD | -9.87% |
| 2018 Q1 | -34.13 Million USD | 6.75% |
| 2018 Q2 | -23.72 Million USD | 30.52% |
| 2018 Q4 | -38.45 Million USD | -55.45% |
| 2017 Q3 | -29.44 Million USD | 3.82% |
| 2017 FY | - USD | -6.38% |
| 2017 Q1 | -11.18 Million USD | 70.93% |
| 2017 Q2 | -30.61 Million USD | -173.72% |
| 2017 Q4 | -36.61 Million USD | -24.33% |
| 2016 Q3 | -14.27 Million USD | 35.6% |
| 2016 Q2 | -22.16 Million USD | 22.64% |
| 2016 FY | - USD | -53.91% |
| 2016 Q4 | -38.47 Million USD | -169.57% |
| 2016 Q1 | -28.65 Million USD | -47.75% |
| 2015 FY | - USD | -124.89% |
| 2015 Q2 | -19.62 Million USD | -510.35% |
| 2015 Q1 | -3.21 Million USD | 29.92% |
| 2015 Q4 | -19.39 Million USD | 22.6% |
| 2015 Q3 | -25.05 Million USD | -27.65% |
| 2014 FY | - USD | -19.79% |
| 2014 Q4 | -4.58 Million USD | 44.97% |
| 2014 Q2 | -7.77 Million USD | 2.92% |
| 2014 Q3 | -8.33 Million USD | -7.29% |
| 2014 Q1 | -8 Million USD | -28.57% |
| 2013 FY | - USD | -270.57% |
| 2013 Q4 | -6.22 Million USD | 8.63% |
| 2013 Q1 | -4.6 Million USD | -8.99% |
| 2013 Q3 | -6.81 Million USD | 7.01% |
| 2013 Q2 | -7.32 Million USD | -59.01% |
| 2012 Q1 | 8.24 Million USD | 288.67% |
| 2012 Q4 | -4.22 Million USD | -26.13% |
| 2012 FY | - USD | 59.96% |
| 2012 Q2 | -4.61 Million USD | -156.04% |
| 2012 Q3 | -3.35 Million USD | 27.41% |
| 2011 Q1 | -4.46 Million USD | 44.05% |
| 2011 Q3 | -3.87 Million USD | 32.64% |
| 2011 Q4 | -4.36 Million USD | -12.66% |
| 2011 FY | - USD | 26.78% |
| 2011 Q2 | -5.75 Million USD | -29.02% |
| 2010 FY | - USD | 8.17% |
| 2010 Q4 | -7.97 Million USD | -80.11% |
| 2010 Q3 | -4.42 Million USD | 4.83% |
| 2010 Q2 | -4.65 Million USD | 21.66% |
| 2010 Q1 | -5.93 Million USD | 52.27% |
| 2009 Q4 | -12.44 Million USD | -437.59% |
| 2009 Q3 | -2.31 Million USD | 43.43% |
| 2009 Q2 | -4.09 Million USD | 43.87% |
| 2009 Q1 | -7.28 Million USD | 63.54% |
| 2009 FY | - USD | 47.17% |
| 2008 Q2 | -9.84 Million USD | -11.59% |
| 2008 Q4 | -19.99 Million USD | -129.12% |
| 2008 Q1 | -8.82 Million USD | -71.24% |
| 2008 FY | - USD | -70.13% |
| 2008 Q3 | -8.72 Million USD | 11.4% |
| 2007 FY | - USD | 34.22% |
| 2007 Q4 | -5.15 Million USD | 39.35% |
| 2007 Q3 | -8.49 Million USD | -11.24% |
| 2007 Q2 | -7.63 Million USD | -16.34% |
| 2007 Q1 | -6.56 Million USD | 31.3% |
| 2006 Q4 | -9.55 Million USD | -0.15% |
| 2006 Q1 | -13.56 Million USD | 16.46% |
| 2006 Q2 | -11.13 Million USD | 17.92% |
| 2006 FY | - USD | 38.01% |
| 2006 Q3 | -9.54 Million USD | 14.32% |
| 2005 Q4 | -16.24 Million USD | -3.32% |
| 2005 Q2 | -19.67 Million USD | -17.97% |
| 2005 Q1 | -16.67 Million USD | -3.27% |
| 2005 Q3 | -15.72 Million USD | 20.1% |
| 2005 FY | - USD | -15.58% |
| 2004 Q4 | -16.15 Million USD | -36.46% |
| 2004 Q1 | -16.47 Million USD | 1.72% |
| 2004 Q2 | -15.91 Million USD | 3.37% |
| 2004 FY | - USD | 4.87% |
| 2004 Q3 | -11.83 Million USD | 25.64% |
| 2003 Q3 | -15.99 Million USD | -0.82% |
| 2003 Q1 | -12.84 Million USD | 13.91% |
| 2003 Q2 | -15.48 Million USD | -23.14% |
| 2003 FY | - USD | -19.07% |
| 2003 Q4 | -16.53 Million USD | -3.33% |
| 2002 FY | - USD | -1710.57% |
| 2002 Q4 | -14.97 Million USD | -18.92% |
| 2002 Q3 | -12.68 Million USD | 3.01% |
| 2002 Q2 | -13.15 Million USD | -18.69% |
| 2002 Q1 | -11.08 Million USD | -119.71% |
| 2001 Q2 | -8.34 Million USD | -11.79% |
| 2001 Q1 | -7.46 Million USD | 6.34% |
| 2001 FY | - USD | -464.58% |
| 2001 Q4 | 21.68 Million USD | 229.83% |
| 2001 Q3 | -43.36 Million USD | -419.3% |
| 2000 Q3 | -5.94 Million USD | 1.45% |
| 2000 Q1 | -5.06 Million USD | 0.0% |
| 2000 Q2 | -6.03 Million USD | -18.94% |
| 2000 Q4 | -7.96 Million USD | -34.06% |
| 2000 FY | - USD | 104.44% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -6.86 Million USD | -2024.694% |
| Jaguar Health, Inc. | -33.13 Million USD | -340.446% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 4.109% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -157.117% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 43.493% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 243.447% |
| ContextLogic Inc. | -324 Million USD | 54.962% |
| MiMedx Group, Inc. | 40.51 Million USD | 460.155% |
| MEI Pharma, Inc. | 26.38 Million USD | 653.161% |
| AlloVir, Inc. | -190.14 Million USD | 23.257% |
| Novavax, Inc. | -487.39 Million USD | 70.06% |
| Aptorum Group Limited | -9.59 Million USD | -1420.2% |
| Ardelyx, Inc. | -55.35 Million USD | -163.62% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 16.934% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -5203.28% |
| Vaxcyte, Inc. | -464.88 Million USD | 68.611% |
| Precigen, Inc. | -89.22 Million USD | -63.544% |
| Pharming Group N.V. | 9.87 Million USD | 1577.412% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 8.252% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -541.086% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -759.337% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 37.505% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -711.886% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -505.195% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -505.195% |
| Bicycle Therapeutics plc | -183.4 Million USD | 20.434% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -66.91% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -403.829% |
| Acelyrin, Inc. | -381.52 Million USD | 61.753% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 27684.877% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -337.081% |
| Senti Biosciences, Inc. | -61.33 Million USD | -137.909% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -29.937% |
| AbCellera Biologics Inc. | -192.15 Million USD | 24.06% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -372.185% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 11.786% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -45359.19% |
| Chimerix, Inc. | -92.97 Million USD | -56.951% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -349.647% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -623.865% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -228.386% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -211.391% |
| Elevation Oncology, Inc. | -41.46 Million USD | -251.904% |
| Alkermes plc | 495.04 Million USD | 129.477% |
| Fortress Biotech, Inc. | -133.64 Million USD | -9.189% |
| Fortress Biotech, Inc. | -133.64 Million USD | -9.189% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -88.671% |
| Dyadic International, Inc. | -8.22 Million USD | -1673.13% |
| ImmuCell Corporation | -2.5 Million USD | -5727.457% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -50045.704% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -11.887% |
| Lantern Pharma Inc. | -15.78 Million USD | -824.348% |
| Immix Biopharma, Inc. | -16.13 Million USD | -804.358% |
| Incyte Corporation | 919.42 Million USD | 115.871% |
| IO Biotech, Inc. | -91.22 Million USD | -59.955% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -105.457% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -632.83% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -154.33% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 7.17% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -1638.018% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -95.047% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 61.596% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 72.973% |
| NextCure, Inc. | -59.03 Million USD | -147.165% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -1363.925% |
| Onconetix, Inc. | -36.7 Million USD | -297.54% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 6629.038% |
| Opthea Limited | -200.01 Million USD | 27.045% |
| PDS Biotechnology Corporation | -40.08 Million USD | -264.037% |
| PureTech Health plc | -11.62 Million USD | -1155.044% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -85.907% |
| Seer, Inc. | -97.88 Million USD | -49.077% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -1132420.34% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -532.856% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -2285.726% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -398.749% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -148.212% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -514.805% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -19.509% |
| ChromaDex Corporation | -3.89 Million USD | -3647.406% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -2019.756% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -29.671% |
| CRISPR Therapeutics AG | -202.7 Million USD | 28.01% |
| Precision BioSciences, Inc. | -32.04 Million USD | -355.415% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 15.273% |
| Innoviva, Inc. | 248.96 Million USD | 158.613% |
| Summit Therapeutics Inc. | 1 Million USD | 14677.822% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -134.616% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -123.245% |
| ESSA Pharma Inc. | -26.45 Million USD | -451.587% |
| GlycoMimetics, Inc. | -39.12 Million USD | -272.997% |
| GT Biopharma, Inc. | 5.97 Million USD | 2540.609% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 29.401% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 268.092% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -184.902% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -1375.932% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 38.33% |
| Aptose Biosciences Inc. | -52.26 Million USD | -179.184% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -35.437% |
| Soligenix, Inc. | -7.85 Million USD | -1758.23% |
| Century Therapeutics, Inc. | -121.2 Million USD | -20.391% |
| Kura Oncology, Inc. | -164.95 Million USD | 11.537% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -82.182% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -1346.798% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -15136.301% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -3286.493% |
| Autolus Therapeutics plc | -156.77 Million USD | 6.918% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -72.371% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -111.481% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -632.036% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 22.903% |
| GRI Bio, Inc. | -10.89 Million USD | -1238.998% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -3131.471% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -19.116% |
| IGM Biosciences, Inc. | -253.35 Million USD | 42.404% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -40.593% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -282.669% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -851.829% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -826.899% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -156.705% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -36.246% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 45.141% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 24.758% |
| Verastem, Inc. | -83.16 Million USD | -75.461% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -188.547% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 7.776% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -27.904% |
| Histogen Inc. | -10.5 Million USD | -1289.355% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -921.898% |
| Surrozen, Inc. | -41.13 Million USD | -254.779% |
| Organovo Holdings, Inc. | -14.8 Million USD | -885.573% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 4550271.5% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -148.537% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -184.486% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -577.487% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -1650.107% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 12.129% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -196.241% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -503.84% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -869.27% |
| Apollomics, Inc. | -171.74 Million USD | 15.035% |
| Amarin Corporation plc | -50.9 Million USD | -186.679% |
| Mesoblast Limited | -61.33 Million USD | -137.929% |
| Turnstone Biologics Corp. | -56.23 Million USD | -159.494% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -1.902% |
| Synaptogenix, Inc. | -8.3 Million USD | -1656.532% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -851.327% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -131.453% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2945.498% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 34111.826% |
| Exelixis, Inc. | 196.6 Million USD | 174.223% |
| Better Therapeutics, Inc. | -38.26 Million USD | -281.381% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -3.193% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 70.533% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1137.1% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 59126.924% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -394.557% |
| Gritstone bio, Inc. | -126.86 Million USD | -15.025% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -124.55% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -3548.149% |
| Avid Bioservices, Inc. | -11.48 Million USD | -1171.004% |
| Insmed Incorporated | -654.73 Million USD | 77.713% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -6386.321% |
| MediWound Ltd. | -4.89 Million USD | -2882.301% |
| OmniAb, Inc. | -49.73 Million USD | -193.427% |
| Alector, Inc. | -142.89 Million USD | -2.122% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -70.803% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -179.827% |
| Zai Lab Limited | -366.57 Million USD | 60.192% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 49.792% |
| Aura Biosciences, Inc. | -83.69 Million USD | -74.35% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 35.217% |
| Immunic, Inc. | -99.11 Million USD | -47.231% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -10.826% |
| Veracyte, Inc. | -49.4 Million USD | -195.339% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -1965.762% |
| FibroGen, Inc. | -261.4 Million USD | 44.177% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1209.793% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -1984.233% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -679.639% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 110.068% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -474.007% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 465.816% |
| TG Therapeutics, Inc. | 26.1 Million USD | 659.096% |
| Galecto, Inc. | -37.51 Million USD | -288.934% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -281.351% |
| Fortrea Holdings Inc. | 167.3 Million USD | 187.223% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -8.671% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -415.432% |
| XBiotech Inc. | -35.76 Million USD | -307.996% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -124.55% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -123.638% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -39.7% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -468.417% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -257.07% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 71.745% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -160.481% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -260241.475% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -25.434% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -558.218% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 37.922% |
| NexImmune, Inc. | -28.16 Million USD | -418.058% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -2540.896% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -1137.454% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 103.135% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -474.685% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1145.814% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -15.954% |
| Ainos, Inc. | -8.77 Million USD | -1563.312% |
| Pluri Inc. | -20.22 Million USD | -621.503% |
| Prothena Corporation plc | -190.1 Million USD | 23.242% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -13.827% |
| Celularity Inc. | -183.94 Million USD | 20.67% |
| Rallybio Corporation | -72.37 Million USD | -101.628% |
| Cue Biopharma, Inc. | -46.05 Million USD | -216.868% |
| MeiraGTx Holdings plc | -57.05 Million USD | -155.774% |
| Omeros Corporation | -163.61 Million USD | 10.81% |
| Humacyte, Inc. | -96.45 Million USD | -51.282% |
| Immunocore Holdings plc | -59.64 Million USD | -144.638% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -653.273% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -498.908% |
| Blueprint Medicines Corporation | -474.61 Million USD | 69.254% |
| CalciMedica, Inc. | -34.18 Million USD | -326.816% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -99.257% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -16.277% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 13.373% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 42.183% |
| Pulmatrix, Inc. | -12.64 Million USD | -1053.914% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -342.65% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -64.947% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 71.179% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -44.172% |
| Cytokinetics, Incorporated | -456.68 Million USD | 68.047% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -337.252% |
| Nutriband Inc. | -5.12 Million USD | -2749.089% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -237.225% |
| Vor Biopharma Inc. | -114.37 Million USD | -27.588% |
| Roivant Sciences Ltd. | -996.51 Million USD | 85.357% |
| Evogene Ltd. | -23.2 Million USD | -528.874% |
| ProKidney Corp. | -147.66 Million USD | 1.182% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -126.116% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -95182.372% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 74.194% |
| CorMedix Inc. | -48.88 Million USD | -198.492% |
| BioLineRx Ltd. | -57.06 Million USD | -155.733% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -30.571% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -72139.604% |
| Atai Life Sciences N.V. | -36.31 Million USD | -301.873% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -83.513% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -79.46% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 47.034% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -374.704% |
| MediciNova, Inc. | -9.87 Million USD | -1376.968% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -15.867% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -9436.264% |
| GeoVax Labs, Inc. | -26.66 Million USD | -447.172% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 35.142% |
| Biomea Fusion, Inc. | -124.62 Million USD | -17.095% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 55.826% |
| Mereo BioPharma Group plc | -26.05 Million USD | -460.04% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 23.335% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 36.539% |
| Absci Corporation | -95.45 Million USD | -52.869% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -386.008% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -36.227% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 37.499% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -538.477% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 29.789% |
| Allakos Inc. | -189.91 Million USD | 23.164% |
| Imunon, Inc. | -19.87 Million USD | -634.088% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -34.502% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 234.711% |
| BioAtla, Inc. | -122.24 Million USD | -19.374% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1137.1% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -825.855% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 51.406% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -252.074% |
| XOMA Corporation | -39.36 Million USD | -270.723% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -47.021% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -24.032% |
| aTyr Pharma, Inc. | -52.17 Million USD | -179.666% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -74.102% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 1.821% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 37.79% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -968.805% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -1714.456% |
| Akari Therapeutics, Plc | -16.8 Million USD | -768.492% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 77428.755% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 132.288% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -2184.122% |
| UroGen Pharma Ltd. | -63.83 Million USD | -128.61% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -114.863% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -1909.139% |
| Orgenesis Inc. | -60.71 Million USD | -140.331% |
| Entera Bio Ltd. | -8.8 Million USD | -1557.474% |
| GH Research PLC | -41.15 Million USD | -254.589% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -471.825% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -77.452% |
| Xencor, Inc. | -125.87 Million USD | -15.929% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -10129.19% |
| Replimune Group, Inc. | -230.19 Million USD | 36.609% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -623.915% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -1233.614% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -2184.122% |
| Portage Biotech Inc. | -18.19 Million USD | -701.824% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -9436.264% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -39.528% |
| OncoCyte Corporation | -23.12 Million USD | -531.077% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1191.321% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1173.685% |
| Purple Biotech Ltd. | -22.22 Million USD | -556.576% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -2176.505% |
| scPharmaceuticals Inc. | -46.06 Million USD | -216.806% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -719.352% |
| HilleVax, Inc. | -132.46 Million USD | -10.16% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -1272.369% |
| Tharimmune, Inc. | -9.3 Million USD | -1468.639% |
| Genprex, Inc. | -31.06 Million USD | -369.805% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 22.185% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -365.408% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -19000.0% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 96799.889% |
| OKYO Pharma Limited | -15.74 Thousand USD | -926644.6% |
| Savara Inc. | -59.13 Million USD | -146.773% |
| Curis, Inc. | -45.13 Million USD | -223.277% |
| Daré Bioscience, Inc. | -30.7 Million USD | -375.299% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -860.586% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -1936.622% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -445.837% |
| BeiGene, Ltd. | -1.12 Billion USD | 87.024% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -795.173% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 66.11% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -61.528% |
| Erasca, Inc. | -121.31 Million USD | -20.29% |
| bluebird bio, Inc. | -167.16 Million USD | 12.705% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -3143.652% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 147.029% |
| DBV Technologies S.A. | -85.98 Million USD | -69.715% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -3143.652% |
| Moderna, Inc. | -3.28 Billion USD | 95.555% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -242.472% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -2483.64% |
| Molecular Templates, Inc. | 1.43 Million USD | 10304.476% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -143.808% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 55.272% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -6.445% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -208.078% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -4.956% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 29.115% |
| MacroGenics, Inc. | 2.01 Million USD | 7334.705% |
| RenovoRx, Inc. | -11.39 Million USD | -1181.159% |
| Adicet Bio, Inc. | -136.53 Million USD | -6.877% |
| Prime Medicine, Inc. | -193.75 Million USD | 24.688% |
| Aditxt, Inc. | -25.45 Million USD | -473.196% |
| Adagene Inc. | -14.95 Million USD | -876.029% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1896.198% |
| Quantum-Si incorporated | -91.8 Million USD | -58.952% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 120.483% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 215.396% |
| SciSparc Ltd. | -5.28 Million USD | -2662.666% |
| Vericel Corporation | 2.86 Million USD | 5195.112% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -153168.633% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -572.727% |
| Generation Bio Co. | -133.3 Million USD | -9.47% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -75.749% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -69.634% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 35.839% |
| Invivyd, Inc. | -196.61 Million USD | 25.782% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 60.999% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -1473.339% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 637.394% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1318.804% |
| 2seventy bio, Inc. | -206.41 Million USD | 29.307% |
| ADMA Biologics, Inc. | 5.12 Million USD | 2950.078% |
| Clene Inc. | -43.24 Million USD | -237.467% |
| Capricor Therapeutics, Inc. | -23 Million USD | -534.205% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -201.017% |
| GeoVax Labs, Inc. | -26.66 Million USD | -447.172% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 51.288% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -297.295% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 719.03% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 3071.821% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -349.246% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 7.879% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 78.676% |
| Evaxion Biotech A/S | -21.4 Million USD | -581.792% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -119.715% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 32.961% |
| Trevena, Inc. | -35.28 Million USD | -313.523% |
| Surrozen, Inc. | -41.13 Million USD | -254.779% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -83.34% |
| Cingulate Inc. | -22.95 Million USD | -535.778% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -1855.824% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -291.396% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -1673.856% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -42.691% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -115.141% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -149.99% |
| Clearmind Medicine Inc. | -8.71 Million USD | -1575.234% |
| Kronos Bio, Inc. | -121.83 Million USD | -19.777% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -96.287% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -5877.028% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -44.727% |
| Statera Biopharma, Inc. | 38.93 Million USD | 474.789% |
| ImmunityBio, Inc. | -436.18 Million USD | 66.545% |
| Korro Bio, Inc. | -80.9 Million USD | -80.367% |
| Kineta, Inc. | -15.71 Million USD | -828.624% |
| BioVie Inc. | -31.95 Million USD | -356.723% |
| Codexis, Inc. | -49.28 Million USD | -196.094% |
| Celularity Inc. | -183.94 Million USD | 20.67% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 34.123% |
| Celcuity Inc. | -58.3 Million USD | -150.256% |
| Virax Biolabs Group Limited | -6.6 Million USD | -2107.911% |
| Cibus, Inc. | -314.58 Million USD | 53.614% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -332.585% |
| IN8bio, Inc. | -28.5 Million USD | -411.942% |
| Kodiak Sciences Inc. | -259.02 Million USD | 43.664% |
| Annexon, Inc. | -141.57 Million USD | -3.072% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -29.596% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -127.31% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -421.996% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 36.558% |
| Eyenovia, Inc. | -24.1 Million USD | -505.342% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 425.84% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -44938.272% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -97.718% |
| Arcellx, Inc. | -64.14 Million USD | -127.491% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -224.175% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -18.18% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -372.521% |
| Moolec Science SA | -52.07 Million USD | -180.216% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -182.766% |
| Geron Corporation | -174.78 Million USD | 16.511% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -261.046% |
| Royalty Pharma plc | 1.88 Billion USD | 107.732% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -22.017% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1464.994% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -603.562% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 12.136% |
| Humacyte, Inc. | -96.45 Million USD | -51.282% |
| Structure Therapeutics Inc. | -102.45 Million USD | -42.422% |
| 89bio, Inc. | -134.46 Million USD | -8.524% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -85.007% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 3701.283% |
| Genelux Corporation | -24.16 Million USD | -503.865% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -331.728% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 10.73% |
| Notable Labs, Ltd. | -14.4 Million USD | -913.361% |
| Liquidia Corporation | -70.05 Million USD | -108.311% |
| Mustang Bio, Inc. | -48.06 Million USD | -203.61% |
| Immunovant, Inc. | -269.97 Million USD | 45.95% |
| Quantum-Si incorporated | -91.8 Million USD | -58.952% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -105.567% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -655.77% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -43.046% |
| Acasti Pharma Inc. | -11.3 Million USD | -1191.249% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -555.743% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -851.829% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 30.682% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -3317.149% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -818.917% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -407.103% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -294.07% |
| PepGen Inc. | -83.58 Million USD | -74.588% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -394.591% |
| United Therapeutics Corporation | 1.38 Billion USD | 110.522% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -537.306% |
| Solid Biosciences Inc. | -93.43 Million USD | -56.179% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -2958.09% |
| Immuneering Corporation | -58.06 Million USD | -151.33% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 4550271.5% |
| Silo Pharma, Inc. | -3.62 Million USD | -3924.142% |
| Belite Bio, Inc | -31.52 Million USD | -362.825% |
| XOMA Corporation | -39.36 Million USD | -270.723% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -116.354% |
| Bionomics Limited | -9.83 Million USD | -1383.42% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -73.75% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -321.673% |
| uniQure N.V. | -253.1 Million USD | 42.345% |
| Cassava Sciences, Inc. | -95.68 Million USD | -52.501% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1896.198% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -12.679% |
| Forte Biosciences, Inc. | -32.47 Million USD | -349.315% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -1712.614% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -417.113% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -44938.272% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1209.793% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -817.703% |
| Altimmune, Inc. | -87.93 Million USD | -65.945% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -58.477% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -321.673% |
| Compugen Ltd. | -12.51 Million USD | -1065.9% |
| Peak Bio, Inc. | -1356.23 USD | -10759431.938% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -200.268% |
| Benitec Biopharma Inc. | -22.49 Million USD | -548.839% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 39.776% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -411.243% |
| Zura Bio Limited | -60.56 Million USD | -140.946% |
| PolyPid Ltd. | -20.26 Million USD | -620.15% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -834.631% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -411.243% |
| Instil Bio, Inc. | -146.12 Million USD | 0.136% |
| argenx SE | -216.02 Million USD | 32.45% |
| Immunome, Inc. | -28.27 Million USD | -416.161% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -201.042% |
| Verona Pharma plc | -52.46 Million USD | -178.122% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -53.974% |
| Shattuck Labs, Inc. | -87.61 Million USD | -66.551% |
| CervoMed Inc. | -2.17 Million USD | -6618.806% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -19.371% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -1049.642% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -202.91% |
| Moolec Science SA | -52.07 Million USD | -180.216% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -751.366% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -11.913% |
| AnaptysBio, Inc. | -143.16 Million USD | -1.928% |
| Design Therapeutics, Inc. | -66.32 Million USD | -120.014% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -80.182% |
| NeurAxis, Inc. | -6.66 Million USD | -2089.573% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -286.554% |
| Lumos Pharma, Inc. | -36.57 Million USD | -299.027% |
| Achilles Therapeutics plc | -70.44 Million USD | -107.155% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -53.974% |
| 180 Life Sciences Corp. | -22.13 Million USD | -559.275% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 2603.308% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -5877.028% |
| Nutriband Inc. | -5.12 Million USD | -2749.089% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -32.963% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -163.249% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -188.673% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -123.546% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -169.681% |
| Palisade Bio, Inc. | -12.28 Million USD | -1088.209% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -221.589% |
| Beam Therapeutics Inc. | -156.47 Million USD | 6.742% |
| Neurogene Inc. | -52.28 Million USD | -179.088% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -6.912% |
| AEON Biopharma, Inc. | -48.36 Million USD | -201.739% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -56.877% |
| Sesen Bio, Inc. | -50.84 Million USD | -187.026% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -78.104% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -1081.569% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 65.86% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -38.715% |
| Athira Pharma, Inc. | -116.7 Million USD | -25.039% |
| Vaccinex, Inc. | -19.74 Million USD | -638.931% |
| HCW Biologics Inc. | -23.57 Million USD | -518.95% |
| XOMA Corporation | -39.36 Million USD | -270.723% |
| Nektar Therapeutics | -243.1 Million USD | 39.975% |
| Arvinas, Inc. | -394.8 Million USD | 63.039% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 77428.755% |
| Merus N.V. | -149.2 Million USD | 2.2% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -56.085% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -366.807% |
| Rezolute, Inc. | -68.42 Million USD | -113.267% |
| Clene Inc. | -43.24 Million USD | -237.467% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -846.195% |
| BeyondSpring Inc. | -21.54 Million USD | -577.456% |
| Synlogic, Inc. | -55.16 Million USD | -164.542% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -1107.68% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -1271.208% |
| Peak Bio, Inc. | -1356.23 USD | -10759431.938% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -349.481% |
| Krystal Biotech, Inc. | 17.9 Million USD | 915.036% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -23.223% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 57.25% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -3067.831% |
| MannKind Corporation | 15.12 Million USD | 1064.532% |
| Ikena Oncology, Inc. | -74.39 Million USD | -96.142% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -1058.771% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 817.883% |
| Gossamer Bio, Inc. | -172.15 Million USD | 15.235% |
| CohBar, Inc. | -12.06 Million USD | -1109.406% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -472.049% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -386.008% |
| Legend Biotech Corporation | -477.87 Million USD | 69.464% |
| Mural Oncology plc | -192.72 Million USD | 24.282% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -27.943% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -803.819% |
| Disc Medicine, Inc. | -91.02 Million USD | -60.312% |
| Champions Oncology, Inc. | -5.05 Million USD | -2787.297% |
| REGENXBIO Inc. | -239.46 Million USD | 39.062% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1261.462% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -161.719% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -276.401% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -29.358% |
| Vaxart, Inc. | -74.72 Million USD | -95.287% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -314.459% |
| Cellectis S.A. | -98.09 Million USD | -48.758% |
| Longeveron Inc. | -20.06 Million USD | -627.438% |
| Repare Therapeutics Inc. | -114.27 Million USD | -27.698% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 66.775% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -95.054% |
| Revolution Medicines, Inc. | -430.58 Million USD | 66.11% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -2220.305% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -373.948% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -95.635% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 3076.219% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -1230.816% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 103.169% |
| Denali Therapeutics Inc. | -179.97 Million USD | 18.919% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -153168.633% |
| Veru Inc. | -89.97 Million USD | -62.182% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -442.912% |
| Cingulate Inc. | -22.95 Million USD | -535.778% |
| Passage Bio, Inc. | -98.34 Million USD | -48.386% |
| Context Therapeutics Inc. | -25.06 Million USD | -482.285% |
| Exicure, Inc. | -15.53 Million USD | -839.082% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 29.185% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -294.645% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -2347.323% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 13.38% |
| Nuvalent, Inc. | -149.49 Million USD | 2.387% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -1694.35% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -69.888% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -383.544% |
| OmniAb, Inc. | -49.73 Million USD | -193.427% |
| Anew Medical, Inc. | -1.3 Million USD | -11117.675% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -1080.233% |
| Lipocine Inc. | -16.32 Million USD | -793.996% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -118.875% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -96.39% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -282.669% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -274.03% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -557.819% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 73.228% |
| Ocugen, Inc. | -64.82 Million USD | -125.098% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -57.636% |
| Q32 Bio Inc. | -86.5 Million USD | -68.694% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -762.078% |
| Alumis Inc. Common Stock | -156.89 Million USD | 6.99% |
| Equillium, Inc. | -12.13 Million USD | -1102.208% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -149.562% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -1746.357% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -673.682% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -212.525% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -37.218% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -715.829% |
| Dominari Holdings Inc. | -22.44 Million USD | -550.285% |
| Edesa Biotech, Inc. | -8.19 Million USD | -1681.703% |
| vTv Therapeutics Inc. | -25.41 Million USD | -474.233% |
| Bio-Techne Corporation | 326.66 Million USD | 144.671% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 62.084% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 167.436% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -11.301% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -289.848% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 3.426% |
| Nkarta, Inc. | -120.48 Million USD | -21.118% |
| BioCardia, Inc. | -11.56 Million USD | -1162.318% |
| Iterum Therapeutics plc | -34.58 Million USD | -321.99% |